HAVCR2 and subcutaneous panniculitis-like T-cell lymphoma: In Southeast Asia, where HAVCR2 p.Y82C MAF is 1.6 x 10-3 [5, 6], this pediatric cohort in which 86.4% of the patients were HAVCR2 p.Y82C homozygotes or heterozygotes confirmed an increased risk of developing SPTCL in the presence of HAVCR2 p.Y82C allele (odds ratio, 2.9 x 103; 95% confidence interval, 1.3 x 103 to 6.1 x 103; P<0.0001; for MAF), corresponding to that previously reported [6].